
GEHC Stock Forecast & Price Target
GEHC Analyst Ratings
Bulls say
GE HealthCare Technologies demonstrates a strong growth outlook, supported by key performance metrics such as organic order growth of 2% year-over-year, a book-to-bill ratio of 1.06x, and a significant backlog growth of 10% year-over-year, providing visibility for future sales. The company's nearly $20 billion backlog, coupled with increasing capital spending expectations from hospital customers, positions GEHC favorably for sustained market demand in the coming years. Furthermore, ongoing margin improvement initiatives and a strategic focus on high-growth areas, including pharmaceutical diagnostics and digital innovations, enhance the potential for revenue growth and profitability enhancement.
Bears say
The financial outlook for GE HealthCare Technologies is negatively impacted by several key factors, including increasing competition in its highly competitive markets and ongoing supply chain risks that could disrupt manufacturing and fulfillment capabilities. The company faces additional challenges from a challenging macroeconomic environment that adversely affects capital purchasing patterns in hospitals and may result in declining demand for its solutions. Furthermore, potential issues related to unsuccessful acquisition integrations and slower adoption of new product introductions pose significant risks to future growth and market share retention.
This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
GEHC Analyst Forecast & Price Prediction
Start investing in GEHC
Order type
Buy in
Order amount
Est. shares
0 shares